Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes

Diabetes Care

Volumn 29, Issue 7, 2006, Pages 1529-1534

  Novak, Vera ^a,e   Last, David ^a   Alsop, David C ^a   Abduljalil, Amir M ^b   Hu, Kun ^a   Lepicovsky, Lukas ^a   Cavallerano, Jerry ^c   Lipsitz, Lewis A ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c JOSLIN DIABETES CENTER   (United States)

^d Hebrew Senior Life   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BRAIN ARTERY; BRAIN BLOOD FLOW; BRAIN SIZE; BRAIN VENTRICLE; CARBON DIOXIDE BREATHING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DIET THERAPY; DISEASE CLASSIFICATION; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; HYPERCAPNIA; HYPERVENTILATION; HYPOCAPNIA; INFLAMMATION; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; SYSTOLIC BLOOD PRESSURE; WHITE MATTER;

AGED; BLOOD FLOW VELOCITY; BRAIN; CEREBROVASCULAR CIRCULATION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE CEREBRAL ARTERY; REGRESSION ANALYSIS; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 33746462348     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0261     Document Type: Article

References (32)

1. Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L: Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 63:1181-1186, 2004
2. Harik SI, La Manna JC: Vascular perfusion and blood-brain glucose transport in acute and chronic hyperglycemia. J Neurochem 51:1924-1929, 1988
3. Trauernicht AK, Sun H, Patel KP, Mayhan WG: Enalapril prevents impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in diabetic rats. Stroke 34:2698-2703, 2003
4. Makimattila S, Malmberg-Ceder K, Hakkinen AM, Vuori K, Salonen O, Summanen P, Yki-Jarvinen H, Kaste M, Heikkinen S, Lundbom N, Roine RO: Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury. J Cereb Blood Flow Metab 24:1393-1399, 2004
5. Dandona P, James IM, Newbury PA, Woollard ML, Beckett AG: Cerebral blood flow in diabetes mellitus: evidence of abnormal cerebrovascular reactivity. Br Med J 29:325-326, 1978
6. Fulesdi B, Limburg M, Bereczki D, Kaplar M, Molnar C, Kappelmayer J, Neuwirth G, Csiba L: Cerebrovascular reactivity and reserve capacity in type II diabetes mellitus. J Diabetes Complications 13:191-199, 1999
7. Kadoi Y, Saito S, Goto F, Fujita N: The effect of diabetes on the interrelationship between jugular venous oxygen saturation responsiveness to phenylephrine infusion and cerebrovascular carbon dioxide reactivity. Anesth Analg 99:325-331, 2004
8. van Swieten JC, van den Hout JH, van Ketel BA, Hijdra A, van Gijn J: Periventricular lesions in the white matter on magnetic resonance imaging in the elderly: a morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 114:761-774, 1991
9. deGroot JC, de Leeuw FE, Ouderk M, Hofman A, Jolles J, Breteler MM: Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology 56:1539-1541, 2001
10. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P: A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32:1318-1322, 2001
11. Longstreth WT, Arnold AM, Beauchamp NJ Jr, Manolio TA, Lefkowitz D, Jungreis C, Hirsch CH, O'Leary DH, Furberg CD: Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 36:56-61, 2005
12. Low PA: Evaluation of autonomic function. Curr Opin Neurol Neurosurg 5:461-463, 1992
13. Aiello LM, Cavallerano JD, Cavallerano AA, Bursell SE: The Joslin Vision Network Innovative Telemedicine Care for Diabetes: preserving human vision. Ophthalmol Clin North Am 13:213-224, 2000
14. Cavallerano AA, Cavallerano JD, Katalinic P, Tolson AM, Aiello LM, Aiello LP, the Joslin Vision Netwrok Research Team: Use of Joslin Vision Network digital-video nonmydriatic retinal imaging to assess diabetic retinopathy in a clinical program. Retina 23:215-223, 2003
15. Serrador JM, Picot PA, Rutt BK, Shoemaker JK, Bondar RL: MRI measures of middle cerebral artery diameter on conscious humans during simulated orthostasis. Stroke 31:1672-1678, 2000
16. Novak V, Novak P, Schondorf R: Accuracy of beat-to-beat noninvasive measurement of finger arterial pressure using the Finapres: a spectral analysis approach. J Clin Monit 10:118-126, 1994
17. Smith SM: Fast robust automated brain extraction. Human Brain Mapping 17:143-155, 2002
18. Wells WM, Kininis R, Grimson WEL, Jolesz F: Adaptive segmentation of MRI data. IEEE Trans Biomed Eng 15:429-442, 1996
19. Dempster A, Laird N, Rubin D: Maximal likelihood from incomplete data via the EM algorithm. J R Stat Soc [Ser B] 39:1-38, 1977
20. Firbank MJ, Coulthard A, Harrison RM, Williams ED: Partial volume effects in MRI studies of multiple sclerosis. Magn Reson Imaging 17:593- 601, 1999
21. Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC: Automated image registration. I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 22:139 -152, 2005
22. Kadoi Y, Hinohara H, Kunimoto F, Saito S, Ide M, Hiraoka H, Kawahara F, Goto F: Diabetic patients have an impaired cerebral vasodilatory response to hypercapnia under propofol anesthesia. Stroke 34:2399-2403, 2003
23. Marstrand JR, Garde E, Rostrup E, Ring P, Rosenbaum S, Mortensen EL, Larsson HB: Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke 34:972-976, 2002
24. Harris AK, Hutchinson JR, Sachidanandam K, Johnson MH, Dorrance AM, Stepp DW, Fagan SC, Ergul A: Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1. Diabetes 54:2638-2644, 2005
25. Kario K, Ishikawa J, Hoshide S, Matsui Y, Morinari M, Eguchi K, Ishikawa S, Shimada K: Diabetic brain damage in hypertension: role of renin-angiotensin system. Hypertension 45:887-893, 2005
26. Bouchard P, Ghitescu LD, Bendayan M: Morpho-functional studies of the blood-brain barrier in streptozotocin-induced diabetic rats. Diabetologia 45:1017-1025, 2002
27. Tomassoni D, Bellagamba G, Postacchini D, Venarucci D, Amenta F: Cerebrovascular and brain microanatomy in spontaneously hypertensive rats with streptozotocin-induced diabetes. Clin Exp Hypertens 26:305-321, 2004
28. El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI: Neuroprotective and blood-retinal barrierpreserving effects of cannabidiol in experimental diabetes. Am J Pathol 168:235-244, 2006
29. Wang P, Ba ZF, Chaudry IH: Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation. Am J Physiol 35:H2535-H2541, 1994
30. Makino N, Maeda T, Sugano M, Satoh S, Watanabe R, Abe N: High serum TNF-alpha level in type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells. J Diabetes Complications 19:347-355, 2005
31. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G: Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 15:1649-1652, 1999
32. Duncan BB, Schmidt MI, Offenbacher S, Wu KK, Savage PJ, Heiss G: Factor VIII and other hemostasis variables are related to incident diabetes in adults: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 22:767-772, 1999